These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31486887)

  • 41. [Diagnostic and prognostic value of tumor markers, scores (clinical and biological) algorithms, in front of an ovarian mass suspected of an epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Bendifallah S; Body G; Daraï E; Ouldamer L
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):134-154. PubMed ID: 30733191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary peritoneal serous papillary carcinoma presenting as a single colonic mass without peritoneal dissemination.
    Kim HS; Sung JY; Park WS; Kim YW
    Intern Med; 2013; 52(2):227-32. PubMed ID: 23318853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary peritoneal clear cell carcinoma: excellent results from paclitaxel and carboplatin combination chemotherapy.
    Ichimura T; Ishiko O; Nishimura S; Kojima T; Shimura K
    Oncol Rep; 2001; 8(6):1243-5. PubMed ID: 11605041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous/intraperitoneal paclitaxel and intraperitoneal carboplatin in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma: a feasibility study.
    Nagao S; Iwasa N; Kurosaki A; Nishikawa T; Ohishi R; Hasegawa K; Goto T; Fujiwara K
    Int J Gynecol Cancer; 2012 Jan; 22(1):70-5. PubMed ID: 22146766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602.
    Onda T; Satoh T; Saito T; Kasamatsu T; Nakanishi T; Nakamura K; Wakabayashi M; Takehara K; Saito M; Ushijima K; Kobayashi H; Kawana K; Yokota H; Takano M; Takeshima N; Watanabe Y; Yaegashi N; Konishi I; Kamura T; Yoshikawa H;
    Eur J Cancer; 2016 Sep; 64():22-31. PubMed ID: 27323348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Primary, papillary serous carcinoma of the peritoneum; a report of experiences].
    Petru E; Heydarfadai M; Pickel H; Lahousen M; Tamussino K
    Geburtshilfe Frauenheilkd; 1992 Sep; 52(9):533-5. PubMed ID: 1397954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary papillary serous carcinoma of the peritoneum in a man.
    Shmueli E; Leider-Trejo L; Schwartz I; Aderka D; Inbar M
    Ann Oncol; 2001 Apr; 12(4):563-7. PubMed ID: 11398893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?
    Sioulas VD; Schiavone MB; Kadouri D; Zivanovic O; Roche KL; O'Cearbhaill R; Abu-Rustum NR; Levine DA; Sonoda Y; Gardner GJ; Leitao MM; Chi DS
    Gynecol Oncol; 2017 Apr; 145(1):15-20. PubMed ID: 28238354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma.
    Ben-Baruch G; Sivan E; Moran O; Rizel S; Menczer J; Seidman DS
    Gynecol Oncol; 1996 Mar; 60(3):393-6. PubMed ID: 8774644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Peritoneal papillary serous carcinoma: clinical report].
    Stagnitti F; Mongardini M; Schillaci F; Scirocchi R; De Petris L; Malizia A; Marenga G; Patrizi V; Priore FM; Corona F; Tiberi R; Di Placido M; Calderisi MD; Longo F
    G Chir; 2002 Oct; 23(10):379-82. PubMed ID: 12611260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary peritoneal papillary serous adenocarcinoma: clinical and management aspects.
    Altaras MM; Aviram R; Cohen I; Cordoba M; Weiss E; Beyth Y
    Gynecol Oncol; 1991 Mar; 40(3):230-6. PubMed ID: 2013445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Re-evaluation of interval debulking surgery in advanced epithelial ovarian cancer].
    Ma Y; Li Y; Cui H; Liang XD; Tang ZJ; Li XP; Zhao Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):355-60. PubMed ID: 22883524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
    Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
    Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary peritoneal carcinoma in a young woman with suspected endometriosis.
    Banz C; von Otte S; Noack F; Diedrich K; Hornung D
    Fertil Steril; 2009 Jul; 92(1):390.e5-7. PubMed ID: 19327764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
    Abaid LN; Micha JP; Rettenmaier MA; Brown JV; Mendivil AA; Lopez KL; Goldstein BH
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):101-7. PubMed ID: 23660691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary Peritoneal Papillary Serous Cystadenocarcinoma - A Rare Malignancy.
    Sahu SK; Agrawal S; Shirazi N; Kapruwan H; Dasgupta P; Ghildiyal D; Singh SN
    Chirurgia (Bucur); 2015; 110(6):570-2. PubMed ID: 26713835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peritoneal disseminated recurrence and lung metastasis after surgery for stage IA uterine papillary serous carcinoma of the endometrium: a case report.
    Kanayama S; Yamada Y; Haruta S; Naruse K; Furukawa N; Kawaguchi R; Yoshida S; Sakata M; Sado T; Kitanaka T; Oi H; Kobayashi H
    Arch Gynecol Obstet; 2008 Sep; 278(3):277-80. PubMed ID: 18193438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Papillary serous carcinoma of the peritoneum.
    Fromm GL; Gershenson DM; Silva EG
    Obstet Gynecol; 1990 Jan; 75(1):89-95. PubMed ID: 2296429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of advanced ovarian cancer in South West Wales - a comparison between primary debulking surgery and primary chemotherapy treatment strategies in an unselected, consecutive patient cohort.
    Drews F; Bertelli G; Lutchman-Singh K
    Cancer Epidemiol; 2017 Aug; 49():85-91. PubMed ID: 28599137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Experiences with primary, papillary serous peritoneal cancer].
    Petru E; Pickel H; Lahousen M; Heydarfadai M
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():121-2. PubMed ID: 1286312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.